We have shown that a single prophylactic vaccination with Her2MPyVLPs or Her2MPtVLPs protected >90% of mice against outgrowth of a tumour cell line expressing the homologous human Her2/neu protein (D2F2/E2) [8], [11]. The gene discussed is ERBB2; the disease is neoplasm.